Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors

Aoife M. Egan; Victor M. Montori

doi:10.7326/ACPJC-2018-169-2-002

Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	JC2
Journal	Annals of internal medicine
Volume	169
Issue number	2
DOIs	https://doi.org/10.7326/ACPJC-2018-169-2-002
State	Published - Jul 17 2018

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/ACPJC-2018-169-2-002

Cite this

@article{b30ee3985a9a4c16a39e797dfdece153,

title = "Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors",

author = "Egan, {Aoife M.} and Montori, {Victor M.}",

year = "2018",

month = jul,

day = "17",

doi = "10.7326/ACPJC-2018-169-2-002",

language = "English (US)",

volume = "169",

pages = "JC2",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "2",

}

TY - JOUR

T1 - Review

T2 - In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors

AU - Egan, Aoife M.

AU - Montori, Victor M.

PY - 2018/7/17

Y1 - 2018/7/17

UR - http://www.scopus.com/inward/record.url?scp=85071355324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071355324&partnerID=8YFLogxK

U2 - 10.7326/ACPJC-2018-169-2-002

DO - 10.7326/ACPJC-2018-169-2-002

M3 - Comment/debate

C2 - 30014091

AN - SCOPUS:85071355324

SN - 0003-4819

VL - 169

SP - JC2

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 2

ER -

Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this